336 related articles for article (PubMed ID: 29274246)
1. The sarcopenia index: A novel measure of muscle mass in lung transplant candidates.
Kashani K; Sarvottam K; Pereira NL; Barreto EF; Kennedy CC
Clin Transplant; 2018 Mar; 32(3):e13182. PubMed ID: 29274246
[TBL] [Abstract][Full Text] [Related]
2. Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers.
Barreto EF; Poyant JO; Coville HH; Dierkhising RA; Kennedy CC; Gajic O; Nystrom EM; Takahashi N; Moynagh MR; Kashani KB
Clin Nutr; 2019 Jun; 38(3):1362-1367. PubMed ID: 29921462
[TBL] [Abstract][Full Text] [Related]
3. The creatinine/cystatin C ratio provides effective evaluation of muscle mass in kidney transplant recipients.
Yanishi M; Kinoshita H; Tsukaguchi H; Kimura Y; Koito Y; Sugi M; Matsuda T
Int Urol Nephrol; 2019 Jan; 51(1):79-83. PubMed ID: 30361963
[TBL] [Abstract][Full Text] [Related]
4. A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer.
Fu X; Tian Z; Wen S; Sun H; Thapa S; Xiong H; Liu H; Li L; Yu S
Nutrition; 2021 Feb; 82():111032. PubMed ID: 33172686
[TBL] [Abstract][Full Text] [Related]
5. A new diagnostic index for sarcopenia and its association with short-term postoperative complications in patients undergoing surgery for colorectal cancer.
Yang J; Zhang T; Feng D; Dai X; Lv T; Wang X; Gong J; Zhu W; Li J
Colorectal Dis; 2019 May; 21(5):538-547. PubMed ID: 30648340
[TBL] [Abstract][Full Text] [Related]
6. Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer.
Tang T; Xie L; Hu S; Tan L; Lei X; Luo X; Yang L; Yang M
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1800-1810. PubMed ID: 35297568
[TBL] [Abstract][Full Text] [Related]
7. Evaluating Muscle Mass by Using Markers of Kidney Function: Development of the Sarcopenia Index.
Kashani KB; Frazee EN; Kukrálová L; Sarvottam K; Herasevich V; Young PM; Kashyap R; Lieske JC
Crit Care Med; 2017 Jan; 45(1):e23-e29. PubMed ID: 27611976
[TBL] [Abstract][Full Text] [Related]
8. Value of Cystatin C-Based Sarcopenia Index in Patients Undergoing Surgery for Renal Tumors.
Yajima S; Nakanishi Y; Ogasawara RA; Imasato N; Hirose K; Katsumura S; Kataoka M; Masuda H
Clin Genitourin Cancer; 2024 Jun; 22(3):102051. PubMed ID: 38423930
[TBL] [Abstract][Full Text] [Related]
9. Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass in older adults: J-SHIPP study.
Tabara Y; Kohara K; Okada Y; Ohyagi Y; Igase M
Clin Nutr; 2020 Jun; 39(6):1857-1862. PubMed ID: 31431305
[TBL] [Abstract][Full Text] [Related]
10. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes.
Osaka T; Hamaguchi M; Hashimoto Y; Ushigome E; Tanaka M; Yamazaki M; Fukui M
Diabetes Res Clin Pract; 2018 May; 139():52-58. PubMed ID: 29496508
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of Muscle Function, Mass, and Quality in Liver Transplant Candidates: Results From the Functional Assessment in Liver Transplantation Study.
Wang CW; Feng S; Covinsky KE; Hayssen H; Zhou LQ; Yeh BM; Lai JC
Transplantation; 2016 Aug; 100(8):1692-8. PubMed ID: 27314169
[TBL] [Abstract][Full Text] [Related]
12. A New Equation to Estimate Muscle Mass from Creatinine and Cystatin C.
Kim SW; Jung HW; Kim CH; Kim KI; Chin HJ; Lee H
PLoS One; 2016; 11(2):e0148495. PubMed ID: 26849842
[TBL] [Abstract][Full Text] [Related]
13. Creatinine/(cystatin C × body weight) ratio is associated with skeletal muscle mass index.
Nishida K; Hashimoto Y; Kaji A; Okamura T; Sakai R; Kitagawa N; Osaka T; Hamaguchi M; Fukui M
Endocr J; 2020 Jul; 67(7):733-740. PubMed ID: 32213726
[TBL] [Abstract][Full Text] [Related]
14. The Ratio Serum Creatinine/Serum Cystatin C (a Surrogate Marker of Muscle Mass) as a Predictor of Hospitalization in Chronic Obstructive Pulmonary Disease Outpatients.
Amado CA; García-Unzueta MT; Lavin BA; Guerra AR; Agüero J; Ramos L; Muñoz P
Respiration; 2019; 97(4):302-309. PubMed ID: 30481791
[TBL] [Abstract][Full Text] [Related]
15. Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular events in patients with obstructive coronary artery disease.
Lu YW; Tsai YL; Chou RH; Kuo CS; Chang CC; Huang PH; Lin SJ
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1509-1515. PubMed ID: 33810966
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia in lung transplantation: a systematic review.
Rozenberg D; Wickerson L; Singer LG; Mathur S
J Heart Lung Transplant; 2014 Dec; 33(12):1203-12. PubMed ID: 25044057
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia index based on serum creatinine and cystatin C is associated with mortality in middle-aged and older adults in Chinese: A retrospective cohort study from the China Health and Retirement Longitudinal Study.
Wu Y; Wang H; Tong Y; Zhang X; Long Y; Li Q; Ren J; Liu C
Front Public Health; 2023; 11():1122922. PubMed ID: 37026117
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry.
Giusto M; Lattanzi B; Albanese C; Galtieri A; Farcomeni A; Giannelli V; Lucidi C; Di Martino M; Catalano C; Merli M
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):328-34. PubMed ID: 25569567
[TBL] [Abstract][Full Text] [Related]
19. Association of Creatinine-to-Cystatin C Ratio with Myosteatosis and Physical Performance in Older Adults: The Japan Shimanami Health Promoting Program.
Tabara Y; Okada Y; Ochi M; Ohyagi Y; Igase M
J Am Med Dir Assoc; 2021 Nov; 22(11):2366-2372.e3. PubMed ID: 33915077
[TBL] [Abstract][Full Text] [Related]
20. Fully Automated Deep Learning Tool for Sarcopenia Assessment on CT: L1 Versus L3 Vertebral Level Muscle Measurements for Opportunistic Prediction of Adverse Clinical Outcomes.
Pickhardt PJ; Perez AA; Garrett JW; Graffy PM; Zea R; Summers RM
AJR Am J Roentgenol; 2022 Jan; 218(1):124-131. PubMed ID: 34406056
[No Abstract] [Full Text] [Related]
[Next] [New Search]
